Blastic plasmacytoid dendritic cell neoplasm presenting with a cutaneous tumor alone as the first symptom of onset: 
A case report and review of literature

Yu,Guohua; Wang,Wei; Han,Yekun; Liu,Jing; Pan,Xubo; Qu,Guimei

doi:10.3892/ol.2014.2759

February-2015 Volume 9 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February-2015 Volume 9 Issue 2

Full Size Image

Case Report

Blastic plasmacytoid dendritic cell neoplasm presenting with a cutaneous tumor alone as the first symptom of onset: A case report and review of literature

Authors:
- Guohua Yu
- Wei Wang
- Yekun Han
- Jing Liu
- Xubo Pan
- Guimei Qu
View Affiliations / Copyright

Affiliations: Department of Pathology, Affiliated Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai, Shandong, P.R. China, Department of Pharmacology, Affiliated Hospital, Binzhou Medical College, Binzhou, Shandong, P.R. China
Pages: 819-821
|
Published online on: December 3, 2014

https://doi.org/10.3892/ol.2014.2759
Expand metrics +

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN), formerly named cluster of differentiation (CD)4+/CD56+ haematodermic neoplasm or blastic natural killer cell lymphoma, is a rare and highly aggressive haematopoietic malignancy. BPDCN typically occurs in the elderly, with a marked predilection for cutaneous involvement. The present study describes a case of BPDCN occurring in a 79‑year‑old male. The patient presented with skin lesions alone, with no evidence of extracutaneous involvement during the course of the disease. BPDCN was diagnosed based on histological and immunohistochemical observations and the patient was subsequently treated with local radiotherapy alone. However, rapid disease progression occurred and the patient succumbed five months after being diagnosed. The current result therefore demonstrated that BPDCN is highly aggressive even without systemic dissemination, and that radiotherapy appears to be ineffective in treating this tumor. The present study emphasizes the importance of pathologists and dermatologists being aware of this uncommon disease in order to avoid misdiagnosis.

View Figures

View References

1	Facchetti F, Jones DM and Petrella T: Blastic plasmacytoid dendritic cell neoplasm. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J and Vardiman JW: 4th edition. IARC Press; Lyon, France: pp. 145–147. 2008
2	Lucioni M, Novara F, Fiandrino G, et al: Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood. 118:4591–4594. 2011. View Article : Google Scholar : PubMed/NCBI
3	Hashikawa K, Niino D, Yasumoto S, et al: Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm. J Am Acad Dermatol. 66:278–291. 2012. View Article : Google Scholar
4	Cota C, Vale E, Viana I, et al: Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm - morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol. 34:75–87. 2010. View Article : Google Scholar
5	Yang CS, Wang J and Chang TK: Congenital blastic plasmacytoid dendritic cell neoplasm. Pediatr Blood Cancer. 58:109–110. 2012. View Article : Google Scholar
6	Muljono A, Graf NS and Arbuckle S: Primary cutaneous lymphoblastic lymphoma in children: series of eight cases with review of the literature. Pathology. 41:223–228. 2009. View Article : Google Scholar : PubMed/NCBI
7	Dargent JL, Delannoy A, Pieron P, et al: Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm. J Cutan Pathol. 38:893–898. 2011. View Article : Google Scholar : PubMed/NCBI
8	Li Y, Li Z, Lin HL, Chen XH and Li BL: Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature. Pathol Res Pract. 207:55–59. 2011. View Article : Google Scholar
9	López V, Martí N, Ferrández A, Martin JM and Jordá E: An atypical presentation of a blastic plasmacytoid dendritic cell tumors. J Cutan Pathol. 37:e50–e52. 2010. View Article : Google Scholar
10	Assaf C, Gellrich S, Whittaker S, et al: CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol. 60:981–989. 2007. View Article : Google Scholar
11	Petrella T, Bagot M, Willemze R, et al: Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 123:662–675. 2005. View Article : Google Scholar : PubMed/NCBI
12	Pongpruttipan T, Kummalue T, Bedavanija A, et al: Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand. Diagn Pathol. 6:792011. View Article : Google Scholar : PubMed/NCBI
13	Rizvi H, Paterson JC, Tedoldi S, et al: Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue. Pathologica. 104:56–64. 2012.PubMed/NCBI
14	Julia F, Dalle S, Duru G, et al: Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients. Am J Surg Pathol. 38:673–680. 2014. View Article : Google Scholar : PubMed/NCBI
15	Dietrich S, Andrulis M, Hegenbart U, et al: Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood Marrow Transplant. 17:1250–1254. 2001. View Article : Google Scholar
16	Pagano L, Valentini CG, Pulsoni A, et al; GIMEMA-ALWP (Gruppo Italiano Malattie EMatologiche dell’Adulto, Acute Leukemia Working Party). Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 98:239–246. 2013. View Article : Google Scholar :
17	Bekkenk MW, Jansen PM, Meijer CJ and Willemze R: CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol. 15:1097–1108. 2004. View Article : Google Scholar : PubMed/NCBI
18	Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK and Jones D: Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Mod Pathol. 19:1555–1562. 2006. View Article : Google Scholar : PubMed/NCBI